Skip to main content

Studienportal Gynäkologie

Menu

Breast Cancer
Ovarian Cancer
Endometrium Cancer
Zervix Cancer
Gyn-Sarkome
English

Newsletter

Email

News from science and practice

New Findings from ASCO 2026

Preliminary Results of the NAPISTAR 1-01 Study

Positive results from the DUO-O study!

Highlights from ESGO 2026 and a new approval!

New final data: Immunotherapy with atezolizumab brings no additional benefit in recurrent ovarian cancer

iuvando und Studienportal Gyn kooperieren

ENGAGe AWARD STUDY GYN

Vision for ESGO 2026-2028

© Studienportal Gyn Imprint | Privacy | Contact

E-mail: info@avisomed.de

English
Deutsch (German)
العربية (Arabic)
Türkçe (Turkish)